Latest News about ARGX
Recent news which mentions ARGX
From Benzinga
From Benzinga
FDA Approves Argenx's Vyvgart Hytrulo Prefilled Syringe For Self-Injection For At Home Use Setting
April 11, 2025
From Benzinga
From Benzinga
Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline
April 09, 2025
From Benzinga
Argenx's Flagship Drug Vyvgart Shows Sustained Disease Control In Rare Neuromuscular Disease Patients
April 08, 2025
From Benzinga
From Benzinga
P/E Ratio Insights for argenx
March 20, 2025
From Benzinga
From Benzinga
Earnings Scheduled For February 27, 2025
February 27, 2025
From Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
February 19, 2025
From Benzinga
From Benzinga
From Benzinga
From Benzinga
$1000 Invested In argenx 5 Years Ago Would Be Worth This Much Today
December 18, 2024
From Benzinga
Biohaven Advances in Immunotherapy: Significant IgG Reduction Achieved with BHV-1300, Gains Analyst Approval
December 17, 2024
From Benzinga
This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
November 12, 2024
From Benzinga
This eBay Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
November 05, 2024
From Benzinga
Argenx Q3 Revenue, EPS Beats Excite Bullish Biotech Analysts: 'Most Enviable I&I Pipeline In Entire Industry'
November 01, 2024
Tickers
ARGX
From Benzinga
This Atlassian Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
November 01, 2024
From Benzinga
This Huntington Ingalls Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
November 01, 2024
From Benzinga
Peeling Back The Layers: Exploring argenx Through Analyst Insights
September 26, 2024
Tickers
ARGX
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.